Frontier AI for drug discovery
Genesis Molecular AI (genesistherapeutics.ai) scores 69 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Technology brands, SaaS brands, in the 22nd percentile of 7704 Healthcare brands.
Genesis Molecular AI, based in Burlingame, is a biotechnology company that combines artificial intelligence with pharmaceutical expertise to discover small molecule medicines. It operates the Pearl and GEMS platforms, which integrate foundation models with physics-based simulation to model molecular interactions at scale. The company partners with pharmaceutical and biotech firms, including Gilead and Incyte, to accelerate small molecule drug discovery and development.
| Brand Name | Genesis Molecular AI |
|---|---|
| Domain | genesistherapeutics.ai |
| Industry | Healthcare, Technology |
| Headquarters | Burlingame |
| Main Competitors | Recursion Pharmaceuticals (85/100), Insilico Medicine (83/100), Isomorphic Labs (79/100), Iambic Therapeutics (71/100), Schrödinger (87/100), Exscientia (80/100), BenevolentAI (74/100), XtalPi (77/100) |
Moz Domain Authority 29/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #2,451,590 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Genesis pairs frontier AI with world-class drug hunters to discover small molecule medicines. Built on Pearl and GEMS. Partnered with Gilead and Incyte." (Meta description: 23 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, Webflow.
Social footprint: verified profiles on LinkedIn, Facebook, Instagram, GitHub; no detected presence on X (Twitter), YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Genesis Molecular AI?", Claude could identify the brand as of September 2026. Genesis Therapeutics (also referred to as Genesis Molecular AI) is a biotech company that uses geometric deep learning and AI-driven molecular modeling to accelerate small molecule drug discovery, partnering with pharma companies to design novel therapeutics. Best known for Its GEMS AI platform for structure-based drug design using deep learning on molecular structures.
When asked "Best brands similar to Genesis Molecular AI?", Claude would recommend Genesis Molecular AI as of September 2026. It's a notable player in AI-driven drug discovery with real pharma partnerships, so it's worth mentioning alongside companies like Insitro or Recursion Pharmaceuticals.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Genesis Molecular AI's main competitors in Healthcare: Recursion Pharmaceuticals (85/100), Insilico Medicine (83/100), Isomorphic Labs (79/100), Iambic Therapeutics (71/100), Schrödinger (87/100).
Sources: Brand Analyzer scan
Genesis Molecular AI has limited AI-search visibility, scoring 34/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 42, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Genesis Molecular AI official site
Genesis Molecular AI is headquartered in Burlingame. Genesis Molecular AI operates in the Healthcare category.
Sources: Wikidata
Genesis Molecular AI scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Genesis Molecular AI official site
Genesis Molecular AI is a biotechnology company headquartered in Burlingame, California, that develops AI-driven technology for discovering small molecule medicines. It combines machine learning with pharmaceutical expertise, using its proprietary Pearl and GEMS platforms to model molecular interactions.
Sources: Genesis Molecular AI official site
Genesis Molecular AI pairs frontier artificial intelligence with drug discovery scientists to identify and develop small molecule medicines. It uses its Pearl and GEMS platforms, which combine foundation models with physics-based simulation, to model molecular interactions at scale and accuracy, accelerating the drug discovery process for pharmaceutical partners.
Sources: Genesis Molecular AI official site
Genesis Molecular AI can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Genesis Molecular AI official site
Genesis Molecular AI offers AI-driven drug discovery services and technology built on its Pearl and GEMS platforms. These platforms combine foundation models with physics-based simulation to model molecular interactions, supporting the discovery and development of small molecule medicines for pharmaceutical and biotech partners.
Sources: Genesis Molecular AI official site
Genesis Molecular AI is known for its Pearl and GEMS platforms, which unify foundation models with physics-based simulation for small molecule drug discovery, and for its partnerships with major pharmaceutical companies Gilead and Incyte.
Sources: Genesis Molecular AI official site
Genesis Molecular AI's technology is used by pharmaceutical and biotech companies and drug discovery researchers seeking AI-driven solutions for small molecule drug development. Known partners include Gilead and Incyte.
Sources: Genesis Molecular AI official site
Genesis Molecular AI scores 34/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Genesis Molecular AI has a weak AI-visibility profile at 34/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #2,451,590 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 29/100 and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Genesis Molecular AI from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Genesis Molecular AI: Federation of Veterinarians of Europe (FVE) (69/100), FujiFilm Cellular Dynamics (69/100), Megadata (69/100), iHeart (69/100).
A step up - brands to learn from: ZT Corporate (71/100), Zaina AI (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.